Browsing: Biotech

Gyan Vardhan05 Nov 2026 13:39IST New Update

Gyan Vardhan05 Nov 2026 13:39IST New Update

Gyan Vardhan05 Nov 2026 13:39IST New Update

T-Therapeutics has bagged $133 million in series B funding to move its next-gen T cell engager therapeutics into the clinic for cancer and autoimmune diseases.

T-Therapeutics has bagged $133 million in series B funding to move its next-gen T cell engager therapeutics into the clinic for cancer and autoimmune diseases.

T-Therapeutics has bagged $133 million in series B funding to move its next-gen T cell engager therapeutics into the clinic for cancer and autoimmune diseases.

British biotech venture capital investment reached £270 million, up 44% from £187 million in the third quarter of last year, according to new figures from the BioIndustry Association (BIA), as the sector heads for its best year since 2021.

Faisal Maliki Baskoro October 30, 2026 | 4:54 pm SHARE URL berhasil di salin. Indian biotech startup Miraqules wins the grand prize at Singapore’s SLINGSHOT 2026, held from Oct. 27 to 29, for its patented StopBleed biomaterial designed to control bleeding within 60 seconds. (Handout/EnterpriseSG)

After buying Actio Biosciences earlier this year, Jazz Pharmaceuticals had some rare disease assets to spare. And so, Setara Biosciences has been formed with $90 million in series A funds to work on the remaining small molecule precision medicine programs.

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free dailyBioPharma Dive newsletter.